Reblozyl 75 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9KC7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,658
Award facts
- Contract value 100% obligated
- $34,658.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,658.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Reblozyl 75 mg vials. The contract has no set-aside designation and represents a competitively awarded task order with performance completion required by January 29, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., one of the nation's largest pharmaceutical distributors serving federal healthcare systems.
This delivery order is issued under Cencora, Inc.'s Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad spectrum of medications, specialty drugs, vaccines, and medical supplies to military healthcare programs and other federal medical institutions worldwide. Reblozyl (luspatercept) is an erythroid maturation agent approved for treating anemia in patients with myelodysplastic syndromes and beta-thalassemia, reflecting the contractor's role in supplying specialized pharmaceutical commodities to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9KC7?
SPE2DR26F9KC7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KC7 worth?
The government has obligated $34,658 on SPE2DR26F9KC7.
Is contract SPE2DR26F9KC7 an order under another contract?
Yes. SPE2DR26F9KC7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KC7 competed?
The extent of competition for SPE2DR26F9KC7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award